Revance Therapeutics (RVNC)
NASDAQ:RVNC

Revance Therapeutics (RVNC) Technical Analysis

578 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Revance Therapeutics’s (RVNC) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting Revance Therapeutics is a Sell.
Revance Therapeutics’s (RVNC) 20-Day exponential moving average is 3.25, while Revance Therapeutics’s (RVNC) share price is $3.635, making it a Buy.
Revance Therapeutics’s (RVNC) 50-Day exponential moving average is 3.28, while Revance Therapeutics’s (RVNC) share price is $3.635, making it a Buy.

Revance Therapeutics (RVNC) Pivot Points

Jul 27, 2024, 02:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.03
3.30
3.47
3.74
3.91
4.18
4.35
Fibonacci
3.30
3.46
3.57
3.74
3.90
4.01
4.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Revance Therapeutics (RVNC) Moving Averages

Jul 27, 2024, 02:04 AM
Period
Simple
Exponential
MA5
3.86Sell
3.70Sell
MA10
3.48Buy
3.51Buy
MA20
3.01Buy
3.25Buy
MA50
3.03Buy
3.28Buy
MA100
3.90Sell
4.16Sell
MA200
5.63Sell
6.86Sell
Revance Therapeutics’s (RVNC) 10-Day exponential moving average is 3.51, while Revance Therapeutics’s (RVNC) share price is $3.635, making it a Buy.
Revance Therapeutics’s (RVNC) 100-Day exponential moving average is 4.16, while Revance Therapeutics’s (RVNC) share price is $3.635, making it a Sell.
Revance Therapeutics’s (RVNC) stock price is $3.635 and Revance Therapeutics’s (RVNC) 50-day simple moving average is 3.03, creating a Buy signal.
Revance Therapeutics’s (RVNC) stock price is $3.635 and Revance Therapeutics’s (RVNC) 100-day simple moving average is 3.90, creating a Sell signal.
Revance Therapeutics’s (RVNC) stock price is $3.635 and Revance Therapeutics’s (RVNC) 200-day simple moving average is 5.63, creating a Sell signal.

Revance Therapeutics (RVNC) Technical Indicators

Jul 27, 2024, 02:04 AM
Name
Value
Implied Action
RSI (14)
60.13
Neutral
STOCH (9,6)
62.55
Neutral
STOCHRSI (14)
68.62
Neutral
MACD (12,26)
0.24
Sell
ADX (14)
28.82
Neutral
Williams %R
-37.22
Buy
CCI (14)
85.60
Neutral
ATR (14)
0.30
-
Ultimate Oscillator
57.75
Neutral
ROC
41.63
Buy
Revance Therapeutics’s (RVNC) Relative Strength Index (RSI) is 60.13, creating a Neutral signal.
Revance Therapeutics’s (RVNC) Trend Strength Indicator (ADX) is 28.82, creating a Neutral signal.
Revance Therapeutics’s (RVNC) Commodity Channel Index (CCI) is 85.60, creating a Neutral signal.
Revance Therapeutics’s (RVNC) Price Rate of Change (ROC) is 41.63, creating a Buy signal.

FAQ

Is RVNC a Buy, Hold, or Sell?
Based on RVNC’s technical indicators, RVNC is a Hold.
    What is RVNC’s RSI (14)?
    RVNC’s RSI (14) is 60.13, which suggests RVNC is a Neutral.
      What is RVNC’s MACD?
      RVNC’s MACD is 0.24, which suggests RVNC is a Sell.
        What is RVNC’s 5-day moving average?
        RVNC’s 5-day moving average is 3.86, which suggests RVNC is a Sell.
          What is RVNC’s 20-day moving average?
          RVNC 20-day moving average is 3.01, which suggests RVNC is a Buy.
            What is RVNC’s 50-day moving average?
            RVNC’s 50-day moving average is 3.03, which suggests RVNC is a Buy.
              What is RVNC’s 200-day moving average?
              RVNC’s 200-day moving average is 5.63, which suggests RVNC is a Sell.
                What is RVNC’s Williams % R (14)?
                RVNC’s Williams % R (14) is -37.22, which suggests RVNC is a Buy.
                  What is RVNC’s CCI (14)?
                  RVNC’s CCI (14) is 85.60, which suggests RVNC is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis